Citadel Advisors’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16M | Buy |
2,202,856
+1,412,892
| +179% | +$18.4M | ﹤0.01% | 2611 |
|
|
2025
Q4 | $13.4M | Buy |
+789,964
| New | +$8.03M | ﹤0.01% | 2854 |
|
|
2025
Q3 | – | Sell |
-32,405
| Closed | -$262K | – | 14282 |
|
|
2025
Q2 | $211K | Sell |
32,405
-29,551
| -48% | -$195K | ﹤0.01% | 10564 |
|
|
2025
Q1 | $501K | Buy |
61,956
+58,738
| +1,825% | +$642K | ﹤0.01% | 8473 |
|
|
2024
Q4 | $39.8K | Sell |
3,218
-934,368
| -100% | -$12.5M | ﹤0.01% | 12615 |
|
|
2024
Q3 | $7.69M | Buy |
937,586
+912,870
| +3,693% | +$5.46M | ﹤0.01% | 3296 |
|
|
2024
Q2 | $123K | Sell |
24,716
-59,913
| -71% | -$342K | ﹤0.01% | 10625 |
|
|
2024
Q1 | $522K | Sell |
84,629
-1,897,623
| -96% | -$9.5M | ﹤0.01% | 8299 |
|
|
2023
Q4 | $10M | Buy |
+1,982,252
| New | +$10.6M | ﹤0.01% | 2842 |
|
|
2023
Q3 | – | Sell |
-3,110
| Closed | -$11.3K | – | 15230 |
|
|
2023
Q2 | $11.3K | Sell |
3,110
-81,443
| -96% | -$329K | ﹤0.01% | 13149 |
|
|
2023
Q1 | $366K | Sell |
84,553
-13,985
| -14% | -$64.1K | ﹤0.01% | 8966 |
|
|
2022
Q4 | $690K | Buy |
+98,538
| New | +$454K | ﹤0.01% | 7569 |
|
|
2022
Q2 | – | Sell |
-21,305
| Closed | -$41K | – | 14242 |
|
|
2022
Q1 | $43K | Buy |
21,305
+6,067
| +40% | +$14.9K | ﹤0.01% | 12900 |
|
|
2021
Q4 | $48K | Sell |
15,238
-35,210
| -70% | -$146K | ﹤0.01% | 13274 |
|
|
2021
Q3 | $247K | Buy |
+50,448
| New | +$306K | ﹤0.01% | 11507 |
|
|
2021
Q2 | – | Sell |
-18,618
| Closed | -$122K | – | 14542 |
|
|
2021
Q1 | $104K | Sell |
18,618
-28,532
| -61% | -$274K | ﹤0.01% | 12442 |
|
|
2020
Q4 | $371K | Sell |
47,150
-611,441
| -93% | -$5.13M | ﹤0.01% | 8700 |
|
|
2020
Q3 | $5.59M | Buy |
+658,591
| New | +$7.22M | ﹤0.01% | 2999 |
|
|
2020
Q2 | – | Sell |
-26,124
| Closed | -$246K | – | 10605 |
|
|
2020
Q1 | $245K | Sell |
26,124
-34,280
| -57% | -$292K | ﹤0.01% | 7670 |
|
|
2019
Q4 | $484K | Sell |
60,404
-13,838
| -19% | -$339K | ﹤0.01% | 6852 |
|
|
2019
Q3 | $1.52M | Buy |
74,242
+17,122
| +30% | +$393K | ﹤0.01% | 4900 |
|
|
2019
Q2 | $1.49M | Sell |
57,120
-22,954
| -29% | -$644K | ﹤0.01% | 5031 |
|
|
2019
Q1 | $3.11M | Sell |
80,074
-146,525
| -65% | -$5.95M | ﹤0.01% | 3695 |
|
|
2018
Q4 | $9.53M | Buy |
+226,599
| New | +$10.1M | 0.01% | 1947 |
|
|
2018
Q2 | – | Sell |
-11,204
| Closed | -$449K | – | 9355 |
|
|
2018
Q1 | $449K | Buy |
+11,204
| New | +$471K | ﹤0.01% | 6078 |
|
Other funds holding WVE
RCM
GP
MC
DCM
6CM
Citadel Advisors's WVE Position: Q1 2026 in Review
Citadel Advisors increased its Wave Life Sciences (WVE) stake by 179% in Q1 2026, buying an estimated $18.4M and bringing the position to 2,202,856 shares worth $16M. The position accounts for ﹤0.01% of the portfolio, ranked #2611.
Citadel Advisors first reported a position in WVE in Q1 2018 and has held it in 25 quarters since. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.
- Citadel Advisors held 2,202,856 shares of Wave Life Sciences worth $16M as of Q1 2026.
- Citadel Advisors bought 1,412,892 Wave Life Sciences shares in Q1 2026, an estimated $18.4M.
- Wave Life Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2611 holding.
- Citadel Advisors first reported a position in Wave Life Sciences in Q1 2018 and has held it in 25 quarters since.
- 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.